The global hydrocortisone market size was valued at US$ 1.1 Bn in 2020 and expected to reach US$ 2.1 billion by 2030, expanding at a CAGR of 4.2% from 2021 to 2030. Rise in cases of adrenocortical insufficiency and increase in investment in research & development are projected to drive the global hydrocortisone market during the forecast period.
Adrenal insufficiency is a serious pathologic condition characterized by decreased production or action of glucocorticoids and/or mineralocorticoids and adrenal androgens. Prevalence of chronic primary adrenal insufficiency in Europe has been doubled from 40 to 70 cases per million population in the 1960s to 93 to 144 cases per million population by the end of 2017. Increase in incidence of chronic diseases of liver, heart, kidneys, and pancreas; and blood disorders have augmented the demand for glucocorticoids such as hydrocortisone.
Rise in Healthcare Spending to Drive Global Market
Increase in patient awareness about personal health boosts the demand for vitamin supplements. Patients are more aware and proactive about their health and are willing to seek a physician's advice at an early stage. Increase in per capita disposable income is encouraging people to spend more on healthcare facilities, which in turn fuels the global hydrocortisone market. Advertisements have increased public visibility of new treatments, thereby generating interest among chronic patients.
Home Treatment for Children Sparks Innovations in Intramuscular Preparations of Hydrocortisone
Several children are prone to the risks of adrenal insufficiency, since they are unable to mount an endogenous cortisol response to stress. Such children usually receive treatment at home by seeking telephone advices from doctors. Thus, companies in the hydrocortisone market should tap into opportunities in child care to broaden their revenue streams.
Many children are administered oral corticosteroids such as hydrocortisone, dexamethasone, and prednisolone on a daily basis since adrenocortical insufficiency is potentially life threatening. Problems arising from such medical conditions have fueled the demand for steroid medicines that are generally administered intramuscularly or intravenously, depending on the severity of the clinical situation. Companies in the hydrocortisone market are increasing the availability of hydrocortisone sodium succinate and hydrocortisone sodium phosphate for treatment of children that require extra steroids.
Dual Release Hydrocortisone Dosage Boosts Metabolism in Hypoadrenalism Patients
Companies in the hydrocortisone market are introducing medicines that do not require a prescription. For instance, in May 2019, Aflofarm— a supplier of Over the Counter drugs (OTC) and medical devices, announced the launch of Maxicortan, a medicine with double dose of hydrocortisone that can be applied locally on skin inflammations and caters to individuals with atopic dermatitis. As such, dermatitis is one the key medical indications that is creating incremental opportunities for companies in the hydrocortisone market. Therapeutic indications such as allergic contact dermatitis, urticarial, and skin reactions after insect bites are also creating revenue streams for pharmaceutical companies.
On the other hand, dual release hydrocortisone is becoming popular as a metabolism improver agent for patients with adrenal insufficiency. Healthcare professionals are recommending once daily dual release hydrocortisone to provide adequate cortisol exposure time. Since conventional GC (Glucocorticoid) therapy is associated with increased morbidity and mortality, gradual increase in the dosage of dual release hydrocortisone has helped to improve hypoadrenalism patient quality of life.
Need for Clinical Trails Validate Lowest Doses of Hydrocortisone for Shock Reversal
Septic shock is a life-threatening condition that has led to high mortality rates. Hence, clinicians recommend corticosteroids such as hydrocortisone to reduce the severity of trauma caused in patients. As such, hydrocortisone medicines are subject to intensive investigation in several clinical trials. Currently, low-dose hydrocortisone is being highly publicized for shock reversal, resulting in lesser adverse events among patients. This has led to better clinical outcomes as compared to placebo.
Although hydrocortisone aids in faster resolution of shock than placebo, the optimal dosage for hemodynamic support during septic shock is still unclear. This explains why the hydrocortisone market is progressing at a modest CAGR of 4.2% during the forecast period, due to lack of reliable clinical evidence. However, growing awareness about the lowest initial dose of hydrocortisone in adults is helping to revive growth for the hydrocortisone market. This awareness is increasing as a result of the rise in the number of randomized clinical trials.
Adrenocortical Insufficiency to Remain Key Indication
Based on indication, the global hydrocortisone market has been divided into adrenocortical insufficiency, adrenergic syndrome, high blood calcium, thyroiditis, rheumatoid arthritis, dermatitis, asthma and chronic obstructive pulmonary disease (COPD), and others. Hydrocortisone is the first line of treatment for the management of adrenocortical insufficiency, thus contributing to the significant share held by the segment. Adrenogenital disorder is a genetic condition limiting hormone production in the adrenal glands. Hydrocortisone is utilized to replace and correct the deficiency of adrenal hormones.
Topical Route of Administration to be Highly Preferred
In terms of route of administration, the global hydrocortisone market has been classified into parenteral, oral, topical, and rectal. The oral segment accounted for a major share of the global hydrocortisone market in 2020. This can be attributed to the fact that most products under the hydrocortisone therapy segment available in the marketplace are administered orally, due to convenience and better patient compliance with the therapy. The topical segment is expected to expand at a lucrative pace during the forecast period. Increase in patient population with skin disorders such as dermatitis is anticipated to drive the segment during the forecast period.
North America to Dominate Global Market
In terms of region, the global hydrocortisone market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global hydrocortisone market in 2020, followed by Europe. North America dominated the global hydrocortisone market in 2020. The region is projected to maintain its dominance and is anticipated to grow at a CAGR of 4.2% during the forecast period. North America’s dominance in the global market can be primarily attributed to high rate of adoption of treatment in a number of indication in the region.
The major players operating in the global hydrocortisone market are Pfizer, Inc., Novartis AG, Mylan N.V., Hikma Pharmaceuticals Plc, GlaxoSmithKline plc, Cipla Inc., Sun Pharmaceutical Industries Ltd., Abbott Laboratories, and Bayer AG.
By Route of Administration
By Distribution Channel
The Hydrocortisone market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Hydrocortisone market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Hydrocortisone market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hydrocortisone market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Hydrocortisone market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Hydrocortisone capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Hydrocortisone by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Hydrocortisone market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Hydrocortisone market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Hydrocortisone market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Hydrocortisone industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Hydrocortisone market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Hydrocortisone market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Hydrocortisone market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Hydrocortisone market. These factors have benefited the growth of the global market for Hydrocortisone. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Hydrocortisone. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Hydrocortisone are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Pulmonary Arterial Hypertension Market (By Drug Class: Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators; By Type: Branded, Generics; By Route of Administration: Oral, Intravenous/ subcutaneous, Inhalational) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Mechanical Ventilator Market (By Product: Critical Care, Neonatal, Transport & Portable; By Ventilation Mode: Invasive, Non-invasive; By End-use: Hospitals, Home Healthcare) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Surgical display Market (By Type: Low-end, Mid-end, High-end) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Agrochemicals Market (By Product: Fertilizer, Crop Protection Chemicals, Plant Growth Regulators; By Application: Cereal & Grains, Oilseeds & Pulses, Fruits & Vegetables) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...
Home Infusion Therapy Market (By Product: Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors; By Application: Anti-infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030Read more...